Preclinical Imaging Market Size, Share, and Trends 2024 to 2034

Preclinical Imaging Market Size and Forecast 2024 to 2034

The global preclinical imaging  market size is estimated at USD 2.92 billion in 2024 and is anticipated to reach around USD 4.45 billion by 2034, expanding at a CAGR of 4.30% between 2024 and 2034.

The market is growing due to increased demand for drug development derived from technological advancements, rising research investments, growing Clinical Research Organizations (CRO) expansions, research infrastructure, and multimodal imaging.

Preclinical Imaging Market Key Takeaways

• By product insight, the optical imaging segment dominated the market in 2024.
• By product insight, the multimodal segment is expected to grow at the fastest rate in the market during the forecast period.
• By application insight, the research and development segment led the market in 2024.
• By application insight, the drug discovery segment is anticipated to grow at the fastest rate during the forecast period.
• By end-use insight, the pharma and biotech companies segment dominated the market in 2024.

U.S. Preclinical Imaging Market Size and Forecast 2024 to 2034

The U.S. preclinical imaging  market size accounted for USD 613.20 million in 2024 and is expected to be worth around USD 956.86 million by 2034, growing at a CAGR of 4.52% between 2024 and 2034.

Maximum revenue was generated through the North American region in the past and there are many factors that support the growth of this market in the North American region. The research infrastructure in the North American region is extremely developed which proves to be a major growth factor. The skilled professionals available in the North American region plays a significant role in the growth of the market. The number of preclinical initiatives taken by the organizations or the projects that are in progress or large in number. The use of technologically advanced equipment is more in the North American region due to which quality products can be obtained. A large number of initiatives are taken by the government in various regions of the North American area which are extremely supportive of the development and research activities for all the projects in the region.

The research and development activities receive a boost in the nations like Canada especially due to the introduction of the programs like tax credits. as the regulatory guidelines are favorable and the cost of research is less in the Asia Pacific region the market growth will be good. These factors will bring more opportunities in the Asia Pacific region for Preclinical Research. The outsourcing industry in clinical research is also growing in developing nations of the world like India and China.

Market Overview

The preclinical imaging market is in reference to the living animal vision which helps in analysis. Imaging modes as well as drug development are extremely important for researchers. The number of funds received all various organizations for research purpose have increased in recent years and these are extremely supportive of Preclinical Research. As the market demand for preclinical imaging has also increased in recent years the market will show significant growth.

The existing market players will lead to the introduction of innovative technologies for molecular imaging and it will also receive a large amount of funding from various organizations and this will lead to the growth of the market during the forecast period. Technological advancements will also play a significant role in the growth of the market as it has led to the introduction of hybrid systems for imaging. 

Preclinical Research is extremely important in transforming the performance of modern medicines and how these medicines are delivered in order to treat and resolve the problems that patients face. As clinical research organizations are also increasing in number the market is expected to grow well. There are many other factors that will help the growth of the market like the policies or the rights that protect the animals due to which the use of these animals for testing will be reduced. The availability of alternative methods in the market like that of computer-based models and micro-dosing is growing rapidly.

Preclinical Imaging Market Growth Factors

Most of the market players are engaged in research and development activities in order to enhance the existing products in the market. These companies are also focused on making investments to launch new products. These are the most important strategies adopted by organizations. The number of partnerships, collaborations, and agreements has also increased in recent years which has led to the introduction and enhancement of better technologies. In order to strengthen the product portfolio, the companies are constantly focusing on expanding their presence in various geographical locations.

The government support received by companies in developing nations will play a significant role in the growth of the market. Translational activities of research have also grown. The regulatory policies in Asian countries have evolved and they are extremely beneficial for the growth of the market. The adoption of novel imaging technologies at the molecular level has also grown significantly. The increase in the number of biotechnology companies and pharmaceutical companies across the globe will lead to the growth of the market.

The demand for multi-modality systems has also increased which will drive market growth in the coming years. The demand for non-invasive procedures on small animals has also increased significantly. The number of funds received by the organizations and the initiatives taken by the organizations for the Preclinical Research will propel the market growth. 

• The number of technological advancements made in the field is high
• Development in the hybrid imaging system will drive the market growth
• the way modern medicines are delivered will be revolutionized by preclinical research
• The revolutionization to health problems and the treatment for health problems will also be revolutionized
• The need for noninvasive techniques for the imaging of small animals is in greater demand which will we increase the need for research

Implementation of Artificial Intelligence in Preclinical Imaging

The applications of artificial intelligence in health diagnostics are expected to be revolutionary. AI integrates many advanced algorithms and machine learning capabilities to process medical images more quickly than before, which can save time for the adjusted time diagnosis to make it more accurate. Pattern recognition and anomaly knowledge across large datasets with AI improve diagnosis accuracy for most diagnoses avoided. It can also serve as a diagnostic prediction to allow early disease detection for better patient outcomes in situations like cancer. 

In addition, AI has a core role in personalized medicine, providing tailored results based on the patient's characteristics and medical history. Nevertheless, AI in diagnostic imaging will face challenges of privacy in data use, the risk of bias in algorithms, and the need for investments in technology and training. There will also be a requirement for sound guidelines and ethical parameters to enforce.

Market Scope

Preclinical Imaging Market Dynamics

Key Market Drivers

• Increase in the number of investments - As there has been a growth in the investments and the funds received for research and development purposes the market is expected to grow well. With the speed at which technological advancements are taking place the market is expected to grow well. The use of imaging systems of the hybrid kind is also driving market growth. Preclinical research has played an important role in transforming modern medicine, especially in the ways how health issues are resolved and treated with the help of modern medicine.
• Increase in clinical research organizations - Clinical research organizations as well as pharmaceutical companies are making use of the in vivo systems in Preclinical Research. The growing demand for imaging techniques hurdles led to the introduction of more and more organizations conducting the research. This research is conducted with the help of advanced devices, especially in developed regions across the world.

Key Market Challenges

• Stringent regulations - As the framework provided by the government bodies for the conduction of research is strict the preclinical imaging market will suffer in the long run. There are many limitations with the procedural and technical aspects and this will hamper the growth of the market in the coming years period there are many restrictions imposed on the testing of animals through the activist that fight for animal rights and this will also hamper the growth of the market during the forecast period.
• High costs - The operational cost for conducting the research is extremely high and the installation of various equipment for conducting the procedures is also expensive and this will hamper the growth of the market during the forecast period.

Key Market Opportunities

Technological Advancements 

Medical imaging is now transforming rapidly because of new technological and methodological innovations. Hybrid imaging modalities like PET/CT, PET/MRI, and SPECT/CT provide for the integral anatomy and function in precise disease detection and monitoring of treatment. Artificial intelligence and machine learning made a revolutionized change in image analysis, enhancing the quality of images and preserving early diagnosis. The Checklist for Artificial Intelligence in Medical Imaging (CLAIM) is being updated to define elements for popular reporting of artificial intelligence advances. Molecular probes and radiopharmaceuticals have broadened the horizon for nuclear imaging techniques, MRI technology has updated on the spatial-temporal resolution and the 3D printings of organs from MRI and CT scans allow precise surgical planning along with personalized treatment strategies.

Product Insights

On the basis of the product, the optical imaging devices segment is expected to have the largest share in the market in the coming years period as a large number of small animals are used in the imaging for the discovery of drugs the market is expected to grow well. The segment of multimodal imaging devices is also expected to show significant growth in the coming years period technological advancements will play a significant role in the growth of the market as it will lead to an introduction of integrated systems like anatomical digital imaging systems and molecular digital imaging systems. these systems help in multiple screenings of a single unit. These are the devices of the new generation that have integrated the technology of imaging and this shall provide maximum growth opportunities in the coming years period the segment of the reagents will also continue to grow in the coming years. Increased digitalization in the field has provided an interface that is user-friendly and it is finding major application in the field of oncology research. 

End-User Insights

On the basis of the end user, biotechnology companies are expected to have the highest share of the market during the forecast period. The amount of research and development work carried out in these companies has grown significantly and the amount of investment made for these activities has also grown. The constant need for advanced drugs will create more demand for research and development work. The use of this technology in biotechnology companies is more due to its application. Research institutes and pharmaceutical companies also make use of preclinical imaging techniques to a great extent. 

Industry Leaders’ Announcements: 

• Dr. Fletcher, leading the imaging frontier, underscored the company's innovation and collaboration, with a special emphasis on the evolving portfolio of advanced imaging tools that would enable researchers to study biology, facilitate workflows, and speed scientific progress.

Preclinical Imaging Market Companies

• Bruker Corporation (US)
• MR Solutions (UK)
• PerkinElmer (US)
• Fujifilm Holdings Corporation (Japan)
• Milabs B.V. (The Netherlands)
• Mediso Ltd. (Hungary)
• Miltenyi Biotec GmbH (Germany)
• LI-COR
• Inc. (US)
• Aspect Imaging (Israel)
• Trifoil Imaging (US)

Recent Developments: 

• In October 2024, Bruker Corporation announced the OptoVolt module, which is an expanding neuroscience research capacity on the Ultima multiphoton microscope platform. This module allows imaging speeds to exceed 1000 frames per second, permitting researchers to measure neural activity with a higher temporal resolution.
• In February 2024, Monopar Therapeutics presented encouraging preclinical imaging and therapeutic efficacy results for the MNPR-101 radiopharmaceutical program targeting cancers having the urokinase plasminogen activator receptor, including breast triple-negative, colorectal, and pancreatic cancers.

Segments Covered in the Report

By Product

• CT Imaging
• MRI Imaging
• PET/SPECT Imaging
• Multi-modal Imaging
• Optical Imaging
• Ultrasound Imaging
• Photoacoustic Imaging
• Reagents
• Services

By End-User

• Biotech Companies
• Pharmaceutical Companies 
• Research Institutes

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)